Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Sickle Cell Disease

Clinical trial NCT07708350 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07708350
Sponsor: Daniel Bauer
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Sickle Cell Disease Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0)

Start date: 2026-08-01
Primary completion: 2028-12-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.